Tech Company Financing Transactions
HiFiBiO Therapeutics Funding Round
Lyfe Capital, Sequoia Capital and Legend Star joined a $37.5 million Series B venture round for HiFiBiO Therapeutics. The round was announced on 5/17/2018.
Transaction Overview
Company Name
Announced On
5/17/2018
Transaction Type
Venture Equity
Amount
$37,500,000
Round
Series B
Investors
Lyfe Capital (Lead Investor) (James Zhao)
Sequoia Capital (Lead Investor) (Lynn Yang)
Proceeds Purpose
Proceeds purposes will be used for the transformation into a multinational biopharmaceutical enterprise with an experienced management team, stronger global presence and rich pipeline of novel antibody drugs to treat cancer and autoimmune disorders.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
237 Putnam Ave.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Liang Schweizer
Chief Financial Officer
Fred Dom
Chief Financial Officer
Philip Sin
Chief Operating Officer
Jeffrey He
Vice President
Luigi Manenti
VP - Administration
Vincent Tse
VP - General Counsel
Xuqiong Wu
VP - R & D
Francisco Adrian
VP - R & D
Nicola Beltraminelli
Browse more venture capital transactions:
Prev: 5/17/2018: Hero Node venture capital transaction
Next: 5/17/2018: EIP Pharma venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs